Cargando…

Hematological changes in SARS-COV-2 positive patients

INTRODUCTION: The novel SARS-CoV-2 infection has been spreading around the world since January 2020 causing the Corona Virus Disease 2019. Leukopenia, lymphopenia and hypercoagulability with elevated D- Dimers have been described in COVID-19 patients to date. This study aimed to clarify if some bloo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urbano, Mafalda, Costa, Elísio, Geraldes, Catarina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784532/ https://www.ncbi.nlm.nih.gov/pubmed/35098036 http://dx.doi.org/10.1016/j.htct.2021.12.001

Ejemplares similares

Hematological Changes in the Second Wave of SARS-CoV-2 in North India
por: Singh, Akanksha, et al.
Publicado: (2022)

Adherence to Sars-CoV2 vaccination in hematological patients
por: Narinx, Justine, et al.
Publicado: (2022)

Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR
por: Pelcovits, Ari, et al.
Publicado: (2021)

Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
por: Tamariz-Amador, Luis-Esteban, et al.
Publicado: (2021)

Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments
por: Wang, Yingying, et al.
Publicado: (2020)

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Malard, Florent, et al.
Publicado: (2021)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases
por: Cattaneo, Chiara, et al.
Publicado: (2020)

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
por: Greenberger, Lee M., et al.
Publicado: (2021)

Depression and burden in caregivers of onco-hematologic patients during SARS-Cov-2 pandemic
por: Di Perna, M., et al.
Publicado: (2023)

Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature
por: Costa, Bruno Almeida, et al.
Publicado: (2022)

Early report on the severity of COVID‐19 in hematologic patients infected with the SARS‐CoV2 omicron variant
por: Ullrich, Fabian, et al.
Publicado: (2022)

Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities
por: Shama, et al.
Publicado: (2023)

Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings
por: Shah, Mansi R, et al.
Publicado: (2020)

Prevalence of Olfactory Dysfuntion in SARS-COV-2 Positive Patients
por: Gaffoor, Nabeela, et al.
Publicado: (2021)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience
por: Galvez, Carlos, et al.
Publicado: (2020)

Descriptive analysis of Cycle Threshold in patients with hematologic malignancies infected with SARS-COV-2
por: Santarelli, Ignacio Martín, et al.
Publicado: (2023)

A Diagnostic Model to Predict SARS-CoV-2 Positivity in Emergency Department Using Routine Admission Hematological Parameters
por: Soloperto, Rossana, et al.
Publicado: (2021)

Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe
por: Midão, Luís, et al.
Publicado: (2021)

Cardiopulmonary and hematological effects of infrared LED photobiomodulation in the treatment of SARS-COV2
por: Pereira, Pâmela Camila, et al.
Publicado: (2023)

SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
por: Haggenburg, Sabine, et al.
Publicado: (2022)

Associations between hematological parameters and disease severity in patients with SARS‐CoV‐2 infection
por: Lin, Sha, et al.
Publicado: (2020)

EUROPEAN OLDER ADULTS FRAIL: FINDINGS FROM THE SURVEY OF HEALTH, AGEING AND RETIREMENT IN EUROPE (SHARE)
por: Manfredi, Giulia, et al.
Publicado: (2019)

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies
por: Wiestner, Adrian
Publicado: (2022)

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
por: Piñana, José Luis, et al.
Publicado: (2022)

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study
por: De Ramón, Cristina, et al.
Publicado: (2020)

Hematological findings in adult patients with SARS CoV‐2 infection at Tygerberg Hospital Cape Town South Africa
por: Abdullah, Ibtisam, et al.
Publicado: (2022)

Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection
por: Romano, Alessandra, et al.
Publicado: (2022)

1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies
por: Zakurdaeva, K., et al.
Publicado: (2021)

Genetic Examination of Hematological Parameters in SARS-CoV-2 Infection and COVID-19
por: Rowland, Bryce, et al.
Publicado: (2022)

Pharmacological Adherence Behavior Changes during COVID-19 Outbreak in a Portugal Patient Cohort
por: Midão, Luís, et al.
Publicado: (2022)

Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study
por: Bai, Bingke, et al.
Publicado: (2021)

SARS-CoV-2 is not found in the sweat of COVID-19 positive patients
por: Arslan, Bengi, et al.
Publicado: (2021)

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
por: Mair, Maximilian J., et al.
Publicado: (2022)

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination
por: Guven, Deniz C, et al.
Publicado: (2022)

SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
por: Ni, Bin, et al.
Publicado: (2022)

Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
por: Pascale, Sara Pasquina, et al.
Publicado: (2022)

P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Tamariz-Amador, L.-E., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research
por: Guven, Deniz C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ro3aitij1rt9kk47eram26e1rc